Oral semaglutide for managing overweight and obesity [ID6188]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 [TSID11827]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and older [ID6542]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Orforglipron for managing overweight and obesity [ID6516]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC